Navigation Links
Scientists solve mystery of polyketide drug formation
Date:4/1/2008

Irvine, Calif., April 1, 2008 Many top-selling drugs used to treat cancer and lower cholesterol are made from organic compounds called polyketides, which are found in nature but historically difficult for chemists to alter and reproduce in large quantities.

For the first time, scientists at UC Irvine have discovered how polyketides form their ringlike shape, making it easier for chemists to manipulate them into new drugs.

The key, they found, is an enzyme called aromatase/cyclase, which forms a C-shape mold in which polyketides can form one molecule at a time. By changing this mold, chemists can control the size and shape of the polyketide, resulting in the formation of new drugs.

Almost every polyketide has rings in its chemical structure, and if we can control ring formation, we can produce more polyketide drugs, said Sheryl Tsai, lead author of this study and an assistant professor of molecular biology and biochemistry and chemistry at UCI. Until now, polyketide ring formation was a mystery that hampered our efforts to produce new drugs.

The research appears online this week in the Proceedings of the National Academy of Sciences.

Polyketide-based drugs and products account for more than $35 billion in sales annually. They include antibiotics that can cure a bacteria infection (tetracycline and erythromycin); anti-cancer drugs used in chemotherapy (doxorubicin and mithramycin); anti-oxidants that help prevent cancer and promote heart strength (EGCG and resverastrol); and drugs that lower cholesterol levels (Zocor). Green tea and red wine also contain beneficial polyketides.

Polyketides are made naturally by bacteria, fungi, plants and marine animals. Those organisms produce polyketides to kill their predators, be it another bacteria or fungi. They can produce different types of polyketides that kill different types of enemies.

Because bacteria do not have arthritis or diabetes, they would not e
'/>"/>

Contact: Jennifer Fitzenberger
jfitzen@uci.edu
949-824-3969
University of California - Irvine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Scientists Uncover How HIV Hides Inside Cells
2. Scientists: New technique identifies molecular biomarkers for disease
3. Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
4. NewYork-Presbyterian/Columbia physician-scientists present at ACCs 57th Annual Scientific Session
5. Dental scientists convene in Dallas
6. Eminent scientists to lecture in Dallas
7. Scientists learn whats up with a class of retinal cells in mice
8. Scientists Isolate Organism That Causes Disfiguring Tropical Disease
9. Scientists uncover how superbug Staph aureus resists our natural defenses
10. Signaling protein helps limit damage in heart attack, Jefferson scientists show
11. Scripps Florida scientists develop a process to disrupt hepatitis C virion production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... ... with Julia Glushko, professional Tennis player for Israel in the Women’s Tennis Association ... for all her training and recovery. , With a focus on technology and ...
(Date:8/27/2015)... ... August 27, 2015 , ... In addition to its existing Doctor of ... third doctoral program at its main campus in Reading: Doctor of Nursing Practice. , ... to prepare advanced practice nurses for the highest level of clinical nursing practice. ...
(Date:8/27/2015)... GREENWICH, CT and OKLAHOMA CITY, OK (PRWEB) , ... ... ... a Great Point Partners (“GPP”) I, LP portfolio company and leading biopharmaceutical contract ... agreement to be acquired by Hepalink USA Inc. (“Hepalink”) for $205.68M in cash. ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... partnership agreement for quality market research promotion on the Internet. MarketPublishers.com is ... Analysis. , Commenting on the partnership agreement, Natalie Aster, Assistant Manager at ...
(Date:8/27/2015)... TX (PRWEB) , ... August 27, 2015 , ... ... cutting edge procedure to relieve vaginal discomfort due to pre- and post-menopause, chemotherapy, and ... using a CO2 laser, which delivers controlled energy to the vaginal tissue, revitalizing cells ...
Breaking Medicine News(10 mins):Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 3Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 2Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 4Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 2Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 3Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 2Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 3
... Sept. 8 , , WHAT: ... growing radio shows-- The CEO Show-- draws a clever analogy ... upcoming Webinar taken from his book titled, Golf and the Art ... the research and educational arm of Beryl, the nation,s leading healthcare-exclusive call ...
... , , , ... Health Integrated, a leading provider of Health Management Solutions, has ... the health plan integrates the management of behavioral health benefits ... solution, Health Integrated will provide Blue Cross of Idaho with ...
... , Nurses to March for Employee ... in Single-Payer Systems , , SAN ... the largest union and professional association of nurses in U.S. history, ... the biennial convention of California,s largest RN organization, the California Nurses ...
... , , LOS ANGELES, Sept. 8 ... obesity epidemic and a general lack of healthy living. In his new ... Help of a Personal Trainer" ( published by AuthorHouse ), ... lost over 60 pounds with the help of a personal trainer, and ...
... , LONDON, Sept. 8 The 2009 Frost ... Risk Management Award is presented to Pronova BioPharma ASA. The ... FDA-approved omega-3 derived prescription drug. Branded Omacor in Europe ... a prescribed adjunct to diet for the treatment of elevated ...
... , WASHINGTON, Sept. 8 /PRNewswire-USNewswire/ ... health care reform, a new analysis by the Center for ... receive benefits under the House health reform bill (H.R. 3200). ... for the new taxpayer-funded affordability credits, there is nothing in ...
Cached Medicine News:Health News:The Beryl Institute Sponsors Free Customer Service Webinar with Robert Reiss 2Health News:Health Integrated Enters into Agreement with Blue Cross of Idaho to 'Carve-in' Behavioral Health Management 2Health News:1,200 RNs Gather in San Francisco Tuesday: Take Next Step to Form Nation's Largest Ever Union of Nurses 2Health News:The Simple ABCs of Weight Loss and Fitness 2Health News:The Simple ABCs of Weight Loss and Fitness 3Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 2Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 3Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 4Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 5Health News:Health Bill Could Benefit 6.6 Million Illegals 2Health News:Health Bill Could Benefit 6.6 Million Illegals 3
(Date:8/27/2015)... and SOUTH SAN FRANCISCO, Calif. ... Pulmonary Fibrosis Foundation (PFF) and Veracyte, ... the organizations are partnering on a U.S. patient ... with interstitial lung diseases (ILDs), including idiopathic pulmonary ... (INTENSITY) survey will assess the steps and time ...
(Date:8/27/2015)... 27, 2015  QB3@953—a San Francisco ... of California (UC) research institute and biotech accelerator— ... to identify and facilitate collaborations to translate early ... The agreement formalizes a relationship between ... team and creates a new channel for DPAc ...
(Date:8/27/2015)... , Spain and CAMBRIDGE, Mass. , Aug. 27, ... presenting at the Rodman & Renshaw 17th Annual Global Investment ... at the St. Regis Hotel, ORYZON will be represented by ... Dr. Buesa will present this ... at the Fontainebleau Room (2nd Floor).  The company is completing ...
Breaking Medicine Technology:Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 2Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 3Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 4QB3@953 Signs Collaboration Agreement with GSK to Identify Early-Stage Drug Discovery Opportunities 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 3ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 4
... EAST SETAUKET, N.Y., Dec. 19, 2011  An article in the ... of the National Academy of Sciences USA , reported ... therapeutic potential in a laboratory model of Gaucher disease  ... and president of Lixte said, "This is a novel ...
... MISSISSAUGA, Ontario, Dec. 19, 2011  Valeant Pharmaceuticals International, ... VRX) announced that effective December 16, 2011, the ... a dermatology unit of Sanofi (EURONEXT: SAN and ... International, Inc. Valeant Pharmaceuticals International, ...
Cached Medicine Technology:Lixte Biotechnology Holdings Compound LB-205 Reported to Have Therapeutic Potential for Gaucher Disease 2Lixte Biotechnology Holdings Compound LB-205 Reported to Have Therapeutic Potential for Gaucher Disease 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: